Cargando…

Stepwise strategy for generating osteoblasts from human pluripotent stem cells under fully defined xeno-free conditions with small-molecule inducers

Clinically relevant human induced pluripotent stem cell (hiPSC) derivatives require efficient protocols to differentiate hiPSCs into specific lineages. Here we developed a fully defined xeno-free strategy to direct hiPSCs toward osteoblasts within 21 days. The strategy successfully achieved the oste...

Descripción completa

Detalles Bibliográficos
Autores principales: Zujur, Denise, Kanke, Kosuke, Onodera, Shoko, Tani, Shoichiro, Lai, Jenny, Azuma, Toshifumi, Xin, Xiaonan, Lichtler, Alexander C., Rowe, David W., Saito, Taku, Tanaka, Sakae, Masaki, Hideki, Nakauchi, Hiromitsu, Chung, Ung-il, Hojo, Hironori, Ohba, Shinsuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Regenerative Medicine 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965656/
https://www.ncbi.nlm.nih.gov/pubmed/31988991
http://dx.doi.org/10.1016/j.reth.2019.12.010
Descripción
Sumario:Clinically relevant human induced pluripotent stem cell (hiPSC) derivatives require efficient protocols to differentiate hiPSCs into specific lineages. Here we developed a fully defined xeno-free strategy to direct hiPSCs toward osteoblasts within 21 days. The strategy successfully achieved the osteogenic induction of four independently derived hiPSC lines by a sequential use of combinations of small-molecule inducers. The induction first generated mesodermal cells, which subsequently recapitulated the developmental expression pattern of major osteoblast genes and proteins. Importantly, Col2.3-Cherry hiPSCs subjected to this strategy strongly expressed the cherry fluorescence that has been observed in bone-forming osteoblasts in vivo. Moreover, the protocol combined with a three-dimensional (3D) scaffold was suitable for the generation of a xeno-free 3D osteogenic system. Thus, our strategy offers a platform with significant advantages for bone biology studies and it will also contribute to clinical applications of hiPSCs to skeletal regenerative medicine.